The Future of the Personal Genome

Genome sequencing has rapidly moved from costing a million dollars to sequence a human genome in 2007 down to close to $1,000 today. With the practicality of costs has come enormous amounts of data available for analysis to drive the development of more personalized medicine by predicting disease risk and more effectively treating devastating diseases such as Parkinson’s, Cancer and ALS. As... [read more]

Genome sequencing has rapidly moved from costing a million dollars to sequence a human genome in 2007 down to close to $1,000 today. With the practicality of costs has come enormous amounts of data available for analysis to drive the development of more personalized medicine by predicting disease risk and more effectively treating devastating diseases such as Parkinson’s, Cancer and ALS. As better tools have been produced to interpret the complex data, new companies and opportunities have emerged, from biotech and diagnostic organizations, to personal genetics groups and testing laboratories.
Register

With these scientific breakthroughs comes a host of issues and opportunities – for example future technologies to enable new tools such as cell phone sequence monitoring; social engineering innovations to secure shared trait data and interpretation software; and the evaluation of cost and business models. This event will explore these and other topics with an esteemed panel of experts who are at the forefront of the Personal Genome opportunity.

Speakers:

Dr. George Church of The Personal Genome Project

Colin Hill, CEO, Co-Founder and President, GNS Healthcare


Jamie Heywood, Co-Founder and Chairman, PatientsLikeMe

Dr. Michael Pellini, President and CEO, Foundation Medicine

Moderating the panel will be
Dr. Kevin Davies, Editor-in-Chief, Bio-IT World
Author of new book The $1,000 Genome and founding editor of Bio-IT World and Nature Genetics.

Copy and paste a Youtube link below submit

Copy and paste a Slideshare link below submit